Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001415889-25-007459

CEO gave up 22,405 shares (to pay taxes)

  • CEO acquired 781 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Wettig Thane CEO 2025-03-06 Shares withheld for taxes −22,038 $0.39 $8,595 397,915 D
Wettig Thane CEO 2025-03-06 Grant or award +781 398,696 D
Wettig Thane CEO 2025-03-06 Shares withheld for taxes −367 $0.39 $143 398,329 D
Loading xslF345X05/form4-03082025_120348.xml…